Published in Cancer Weekly, January 4th, 2011
"Mutations in the p53 tumour-suppressor pathway are common in human cancer and significant efforts...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.